Evidence map›Paper›PMID 29899416›Full record

ArticleScientific reports2018

Clinical features, fungal load, coinfections, histological skin changes, and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix brasiliensis.

Elaine Waite de Souza, Cintia de Moraes Borba, Sandro Antonio Pereira, Isabella Dib Ferreira Gremião, Ingeborg Maria Langohr, Manoel Marques Evangelista Oliveira, Raquel de Vasconcellos Carvalhaes de Oliveira, Camila Rocha da Cunha, Rosely Maria Zancopé-Oliveira, Luisa Helena Monteiro de Miranda and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 70 citations in OpenAlex.

  1. Assessing the persistence ofMicrobiology spectrum · 2026
    Article
  2. Environmental isolation ofVeterinary record open · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Differential Recognition of Clinically RelevantJournal of fungi (Basel, Switzerland) · 2023
    Article
  12. Journal of fungi (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Current Progress inJournal of fungi (Basel, Switzerland) · 2023
    Review
  15. Differential Recognition of Clinically RelevantJournal of fungi (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Sporotrichosis Outbreak Due toJournal of fungi (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Elaine Waite de SouzaEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Cintia de Moraes BorbaOswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0003-3210-0623
Sandro Antonio PereiraEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Isabella Dib Ferreira GremiãoEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Ingeborg Maria LangohrSchool of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States of America.ORCID 0000-0001-7366-4391
Manoel Marques Evangelista OliveiraEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0001-7670-9225
Raquel de Vasconcellos Carvalhaes de OliveiraEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0001-9387-8645
Camila Rocha da CunhaEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0001-7831-3689
Rosely Maria Zancopé-OliveiraEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Luisa Helena Monteiro de MirandaEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0003-3689-4109
Rodrigo Caldas MenezesEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. rodrigo.menezes@ini.fiocruz.br.ORCID 0000-0003-1853-3449
Fundação Oswaldo Cruz · BRLouisiana State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zoonotic sporotrichosis caused by the fungus Sporothrix brasiliensis is usually severe in cats. This study investigated the associations between clinical features, fungal load, coinfections, histological skin changes, and response to itraconazole in cats with sporotrichosis caused by S. brasiliensis. Fifty-two cats with skin lesions and a definitive diagnosis of sporotrichosis were treated with itraconazole for a maximum period of 36 weeks. The animals were submitted to clinical examination and two subsequent collections of samples from the same skin lesion for fungal diagnosis and histopathology, as well as serology for feline immunodeficiency (FIV) and leukaemia (FeLV) viruses. Thirty-seven (71%) cats were clinically cured. Nasal mucosa lesions and respiratory signs were associated with treatment failure. Cats coinfected with FIV/FeLV (n = 12) had a lower neutrophil count in the lesion. A high fungal load in skin lesions was linked to young age and treatment failure, as well as to a longer time of wound healing, poorly formed granulomas and fewer neutrophils, macrophages and lymphocytes in these lesions. These results indicate that itraconazole is effective, but nasal mucosal involvement, respiratory signs and high fungal loads in skin lesions are predictors of treatment failure that will assist in the development of better treatment protocols for cats.

Indexed as

AnimalsAntifungal AgentsCat DiseasesCatsCoinfectionFeline Acquired Immunodeficiency SyndromeFemaleHost-Pathogen InteractionsItraconazoleLymphocytesMacrophagesMaleNeutrophilsSkinSporothrixSporotrichosisAntifungal AgentsItraconazole

Identifiers

PMID29899416
PMCPMC5998065
OpenAlexW2805659004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.